MoonLake Immunotherapeutics (MLTX) stock
MLTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$11.25−0.48 (-4.09%)
Close on Nov 17, 2026Market cap $957.45MP/E –Yield –
MoonLake Immunotherapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
MoonLake Immunotherapeutics's market cap was $933.97M on Nov 11, 2026, against $868.28M a year earlier. Over the last 5 years it ranged from $28.38M to $4.00B, with a median of $1.93B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $933.97M | +12.1% |
| 2025 | Dec 31, 2025 | $833.50M | -75.2% |
| 2024 | Dec 31, 2024 | $3.36B | +26.4% |
| 2023 | Dec 29, 2023 | $2.66B | +958.2% |
| 2022 | Dec 30, 2022 | $251.45M | +784.4% |
| 2021 | Dec 31, 2021 | $28.43M | – |
See a number that looks wrong?